Prognostic factorsofsurvival inarandomizedphaseIIItrial (MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer

Josep Tabernero, E. Gabrielachiorean, Jeffrey R. Infante, Sunil R. Hingorani, Vinod Ganju, Colin Weekes, Werner Scheithauer, Ramesh K. Ramanathan, David Goldstein, Darryl N. Penenberg, Alfredo Romano, Stefano Ferrara, Daniel D. Von Hoff

Research output: Contribution to journalArticleResearchpeer-review

80 Citations (Scopus)

Fingerprint Dive into the research topics of 'Prognostic factorsofsurvival inarandomizedphaseIIItrial (MPACT)of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences